Invesco’s SpyGlass Pharma SGP Stock Holding History

Invesco’s Portfolio SGP Stock Details SGP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$201K	Buy	+7,736	New	+$191K	﹤0.01%	3605

Other funds holding SGP

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Virtus Investment Advisers Hartford, Connecticut $453M AUM 48.99% 1-Year Est. Return

Invesco's SGP Position: Q3 2026 in Review

Invesco opened a new position in SpyGlass Pharma (SGP) in Q3 2026: 7,736 shares worth $201K. The stake represents ﹤0.01% of the portfolio and ranks #3605 among its holdings.

34 funds tracked by Wall St. Rank hold SGP as of Q3 2026.

Invesco held 7,736 shares of SpyGlass Pharma worth $201K as of Q3 2026.
SpyGlass Pharma was a new Invesco position in Q3 2026.
SpyGlass Pharma made up ﹤0.01% of Invesco's portfolio in Q3 2026, its #3605 holding.
34 funds tracked by Wall St. Rank held SpyGlass Pharma as of Q3 2026.

Based on Invesco's 13F filing for Q3 2026, filed 12 Nov 2026.